Gaetano et al., 1995 - Google Patents
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsGaetano et al., 1995
View PDF- Document ID
- 2601626458701122099
- Author
- Gaetano C
- Manni I
- Bossi G
- Piaggio G
- Soddu S
- Farina A
- Helman L
- Sacchi A
- Publication year
- Publication venue
- European Journal of Cancer
External Links
Snippet
We report the first evidence that differential transcriptional regulation of human chromogranin A (CHGA) gene expression occurs during in vitro treatment of tumorigenic neuroblastoma (NB) cells with retinoic acid (5 pM) and/or dibutyryl-cAMP (1 mM). The CHGA …
- 206010029260 Neuroblastoma 0 title abstract description 52
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blok et al. | Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. | |
| Buckbinder et al. | Induction of the growth inhibitor IGF-binding protein 3 by p53 | |
| Evans-Storms et al. | Regulation of apoptosis by steroid hormones | |
| DE69737290T2 (en) | SUBSTRATE CATCHING PROTEIN TYROSINE PHOSPHATASE | |
| US20030060613A1 (en) | Novel use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease | |
| US11560406B2 (en) | Anti-androgen peptides and uses thereof in cancer therapy | |
| Stack et al. | Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells | |
| Xu et al. | Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells | |
| Hirvonen et al. | Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines | |
| Gaetano et al. | Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cells | |
| Fan et al. | Altered gene structure and tissue expression of islet amyloid polypeptide in the chicken. | |
| Lloyd et al. | Transcription factors in normal and neoplastic pituitary tissues | |
| Daws et al. | Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol | |
| US5571791A (en) | Modified polypeptide fragments of the glucocorticoid receptor | |
| Zhong et al. | Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells | |
| CN109810959A (en) | A protein polypeptide that binds to KEAP1 and regulates NRF2 protein stability | |
| US5876972A (en) | Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation | |
| DE60130686T2 (en) | FUNCTIONAL FRAGMENT OF LEPTIN RECEPTOR | |
| CA2140814A1 (en) | Use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease | |
| Terrioux et al. | Effect of 5′-deoxy-5′-S-isobutyl-adenosine (siba) on mouse mammary tumour cells and on the expression of mouse mammary tumour virus | |
| DE19882435B4 (en) | A method of inhibiting cancer cell growth with a pRb2 / p130 expressing vector | |
| KR20010022235A (en) | Pharmaceuticals for modulating hormone responsiveness | |
| US20040248139A1 (en) | Eit-6, a polypeptide encoded by an estrogen regulated gene | |
| JP2003511069A (en) | Thyroid hyperplasia and tumor nucleic acid sequences | |
| Bouillard et al. | Size heterogeneity of affinity labeled estrogen receptors in the MtTF4 tumor whose growth is inhibited by estradiol, in pituitary gland and uterus |